Concepedia

Gabriel Figueroa‐Parra

GF

Statistics

Publications

10

Citations

204

H-Index

10

Active since

2017

Affiliations

Mayo Clinic(Current)

Mayo Clinic in Arizona

Mayo Clinic in Florida

Universidad Autónoma de Nuevo León

Massachusetts General Hospital

Gabriel Figueroa‐Parra is an author at Mayo Clinic specializing in covid-19 epidemiology, medicine, and risk.

ORCID

Top concepts

Publications per year

2017–2025

10

Publications

10

Risk of severe COVID-19 outcomes associated with rheumatoid arthritis and phenotypic subgroups: a retrospective, comparative, multicentre cohort study

Gabriel Figueroa‐Parra, Emily Gilbert, Maria O Valenzuela-Almada et al. · The Lancet Rheumatology · 2022 · 44 citations · Full text

, , +12

2024 American College of Rheumatology (<scp>ACR</scp>) Guideline for the Screening, Treatment, and Management of Lupus Nephritis

Lisa R. Sammaritano, Anca Askanase, Bonnie L. Bermas et al. · Arthritis & Rheumatology · 2025 · 38 citations

Knowledge and attitudes about influenza vaccination in rheumatic diseases patients

Gabriel Figueroa‐Parra, Jorge Antonio Esquivel‐Valerio, L. Santoyo-Fexas et al. · Human Vaccines & Immunotherapeutics · 2020 · 30 citations · Full text

2024 American College of Rheumatology (<scp>ACR</scp>) Guideline for the Screening, Treatment, and Management of Lupus Nephritis

Lisa R. Sammaritano, Anca Askanase, Bonnie L. Bermas et al. · Arthritis Care & Research · 2025 · 19 citations · Full text

DNA vaccine encoding human papillomavirus antigens flanked by a signal peptide and a KDEL sequence induces a potent therapeutic antitumor effect

José Juan Perez‐Trujillo, Rodolfo Garza-Morales, Jose A. Barron-Cantu et al. · Oncology Letters · 2017 · 18 citations · Full text

1–5 of 10